Home  -  About us  -  Editorial board  -  Search  -  Ahead of print  -  Current issue  -  Archives  -  Instructions  -  Subscribe  -  Contacts  -  Advertise - Login 

    Article Cited by others


Vismodegib hedgehog-signaling inhibition and treatment of basal cell carcinomas as well as keratocystic odontogenic tumors in Gorlin syndrome

Booms Patrick, Harth Marc, Sader Robert, Ghanaati Shahram

Year : 2015| Volume: 5| Issue : 1 | Page no: 14-19

   This article has been cited by
1 Adjunctive Strategies for Benign Maxillofacial Pathology
Zachary S. Peacock
Oral and Maxillofacial Surgery Clinics of North America. 2019;
[Pubmed]  [Google Scholar] [DOI]
2 Effect of the sonic hedgehog inhibitor GDC-0449 on an in vitro isogenic cellular model simulating odontogenic keratocysts
Jiemei Zhai,Heyu Zhang,Jianyun Zhang,Ran Zhang,Yingying Hong,Jiafei Qu,Feng Chen,Tiejun Li
International Journal of Oral Science. 2019; 11(1)
[Pubmed]  [Google Scholar] [DOI]
3 Immunohistochemical Characterization of Reactive Epithelial Changes in Odontogenic Keratocysts
Dorottya Cserni,Tamás Zombori,Anette Stájer,Annamária Rimovszki,Gábor Cserni,Zoltán Baráth
Pathology & Oncology Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
4 Serial ultra-deep sequencing of circulating tumor DNA reveals the clonal evolution in non-small cell lung cancer patients treated with anti-PD1 immunotherapy
Li Li,Yubo Wang,Weiwei Shi,Mengxiao Zhu,Zhulin Liu,Nuo Luo,Yanwu Zeng,Yong He
Cancer Medicine. 2019;
[Pubmed]  [Google Scholar] [DOI]
5 Use of Topical 5-Fluorouracil for Keratocystic Odontogenic Tumors of Gorlin-Goltz Syndrome as a New Targeted Therapy: A Case Report and Review of Literature
hossein shiran,SH Shafaei Fard,S Hakimi,A Azari Pour Esfahani
Journal of Research in Dental and Maxillofacial Sciences. 2019; 4(4): 43
[Pubmed]  [Google Scholar] [DOI]
6 Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets
E T Aristizabal Prada,C J Auernhammer
Endocrine Connections. 2018; 7(1): R1
[Pubmed]  [Google Scholar] [DOI]
7 The relevance of a suppressor of fused (SUFU) mutation in the diagnosis and treatment of Gorlin syndrome
Taylor Ogden,Shauna Higgins,David Elbaum,Ashley Wysong
JAAD Case Reports. 2018; 4(2): 196
[Pubmed]  [Google Scholar] [DOI]
8 Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: A systematic review
Daniel M. Girardi,Andrea C.B. Silva,Juliana Florinda M. Ręgo,Renata A. Coudry,Rachel P. Riechelmann
Cancer Treatment Reviews. 2017; 56: 28
[Pubmed]  [Google Scholar] [DOI]
9 Controversies in Oral and Maxillofacial Pathology
Zachary S. Peacock
Oral and Maxillofacial Surgery Clinics of North America. 2017; 29(4): 475
[Pubmed]  [Google Scholar] [DOI]
10 Molecular Signaling in Benign Odontogenic Neoplasia Pathogenesis
Hope M. Amm,Mary MacDougall
Current Oral Health Reports. 2016;
[Pubmed]  [Google Scholar] [DOI]
11 Development of mediastinal lymphoma after radiotherapy for concurrent medulloblastoma and PNET in a patient with Gorlin syndrome
Tao Jiang,Junmei Wang,Ying Wang,Chunde Li
World Journal of Surgical Oncology. 2016; 14(1)
[Pubmed]  [Google Scholar] [DOI]
12 Transcriptome Variability in Keratocystic Odontogenic Tumor Suggests Distinct Molecular Subtypes
Shijia Hu,Kimon Divaris,Joel Parker,Ricardo Padilla,Valerie Murrah,John Timothy Wright
Scientific Reports. 2016; 6: 24236
[Pubmed]  [Google Scholar] [DOI]
13 Topical 5-Fluorouracil is a Novel Targeted Therapy for the Keratocystic Odontogenic Tumor
Nicholas J. Ledderhof,Marco F. Caminiti,Grace Bradley,David K. Lam
Journal of Oral and Maxillofacial Surgery. 2016;
[Pubmed]  [Google Scholar] [DOI]


Read this article